Skip to main content
Erschienen in: Clinical Research in Cardiology 1/2012

01.01.2012 | Original Paper

A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study

verfasst von: Colin J. Petrie, Adriaan A. Voors, Michele Robertson, Dirk J. van Veldhuisen, Henry J. Dargie

Erschienen in: Clinical Research in Cardiology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

In patients with cardiovascular disease, a high pulse pressure is related to an increased risk of cardiovascular events but in patients with advanced heart failure, a low pulse pressure is predictive of adverse (cardiovascular) events.

Aim

We studied the prognostic importance of pulse pressure in a group of post-myocardial infarction patients, with and without signs and symptoms of heart failure. Subjects had been randomised in the CAPRICORN clinical trial, and followed up for a mean of 1.3 years.

Methods

Blood pressure was measured in 1,955 patients with a left ventricular ejection fraction ≤40%, between 3 and 21 days post myocardial infarction. Cox proportional survival models were reproduced for those with Killip Class I (n = 1342) versus classes II/III/IV heart failure (n = 613).

Results

Overall mean (SD) age was 63 (12) years, mean (SD) left ventricular ejection fraction 33(6)%, mean (SD) baseline blood pressure was 121 (17)/74 (10) mmHg and most (73%) were male. In patients with Killip Class 1, pulse pressure was not predictive for any outcome. However, in patients with Killip Class II–IV, a low pulse pressure independently predicted all cause mortality (HR 0.83 per 10 mmHg, CI 0.71–0.98, p = 0.025), cardiovascular mortality (HR 0.83 per 10 mmHg, CI 0.70–0.98, p = 0.025) and sudden death (HR 0.77 per 10 mmHg, CI 0.60–1.00, p = 0.047). A lower pulse pressure did not predict hospitalisation for worsening heart failure.

Conclusion

A low pulse pressure is an independent predictor of mortality in subjects with depressed left ventricular ejection fraction after a recent myocardial infarction and evidence of Killip Class II–IV heart failure.
Literatur
1.
Zurück zum Zitat Voors AA, Petrie CJ, Petrie MC, Charlesworth A, Hillege HL, Zijlstra F, McMurray JJ, van Veldhuisen DJ (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J 26:1759–1764PubMedCrossRef Voors AA, Petrie CJ, Petrie MC, Charlesworth A, Hillege HL, Zijlstra F, McMurray JJ, van Veldhuisen DJ (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J 26:1759–1764PubMedCrossRef
2.
Zurück zum Zitat Petrie CJ, Voors A, van Veldhuisen DJ (2009) Low pulse pressure is an independent predictor of mortality in non ischemic, but not in ischemic advanced heart failure patients. Int J Cardiol 131:336–344PubMedCrossRef Petrie CJ, Voors A, van Veldhuisen DJ (2009) Low pulse pressure is an independent predictor of mortality in non ischemic, but not in ischemic advanced heart failure patients. Int J Cardiol 131:336–344PubMedCrossRef
3.
Zurück zum Zitat Schillaci G, Di Luzio S, Coluccini M, Gonzini L, Porcu M, Pozzar F, Maggioni AP, Italian Network of Congestive Heart Failure Registry (2004) A low pulse pressure is an independent predictor of mortality in heart failure: data from a large nationwide cardiology database (IN-CHF Registry). Ital Heart J 5:892–898PubMed Schillaci G, Di Luzio S, Coluccini M, Gonzini L, Porcu M, Pozzar F, Maggioni AP, Italian Network of Congestive Heart Failure Registry (2004) A low pulse pressure is an independent predictor of mortality in heart failure: data from a large nationwide cardiology database (IN-CHF Registry). Ital Heart J 5:892–898PubMed
4.
Zurück zum Zitat Yildiran T, Koc M, Bozkurt A, Sahin DY, Unal I, Acarturk E (2010) Low pulse pressure as a predictor of death in patients with mild to advanced heart failure. Tex Heart Inst J 37(3):284–290PubMed Yildiran T, Koc M, Bozkurt A, Sahin DY, Unal I, Acarturk E (2010) Low pulse pressure as a predictor of death in patients with mild to advanced heart failure. Tex Heart Inst J 37(3):284–290PubMed
5.
Zurück zum Zitat Aronson D, Burger AJ (2004) Relation between pulse pressure and survival in patients with decompensated heart failure. Am J Cardiol 93:785–788PubMedCrossRef Aronson D, Burger AJ (2004) Relation between pulse pressure and survival in patients with decompensated heart failure. Am J Cardiol 93:785–788PubMedCrossRef
6.
Zurück zum Zitat Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA (1997) Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation 96:4254–4260PubMed Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA (1997) Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation 96:4254–4260PubMed
7.
Zurück zum Zitat CAPRICORN Investigators (2001) Effect of carvedilol on outome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 57:138–190 CAPRICORN Investigators (2001) Effect of carvedilol on outome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 57:138–190
8.
Zurück zum Zitat Dargie HJ, The CAPRICPORN Steering Committee (2000) Design and methodology of the CAPRICORN trial—a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Eur J Heart Fail 2(3):325–332PubMedCrossRef Dargie HJ, The CAPRICPORN Steering Committee (2000) Design and methodology of the CAPRICORN trial—a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Eur J Heart Fail 2(3):325–332PubMedCrossRef
9.
Zurück zum Zitat Dart AM, Kingwell BA (2001) Pulse pressure. A review of mechanisms and clinical relevance. J Am Coll Cardiol 37(4):975–984PubMedCrossRef Dart AM, Kingwell BA (2001) Pulse pressure. A review of mechanisms and clinical relevance. J Am Coll Cardiol 37(4):975–984PubMedCrossRef
10.
Zurück zum Zitat Fosbøl EL, Seibaek M, Brendorp B, Moller DV, Thune JJ, Gislason GH, Torp-Pedersen C, Køber L, Danish Investigations and Arrhythmia ON Dofetilide Study Group (2010) Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study. Int J Cardiol 140(3):279–286PubMedCrossRef Fosbøl EL, Seibaek M, Brendorp B, Moller DV, Thune JJ, Gislason GH, Torp-Pedersen C, Køber L, Danish Investigations and Arrhythmia ON Dofetilide Study Group (2010) Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study. Int J Cardiol 140(3):279–286PubMedCrossRef
11.
Zurück zum Zitat Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112(24):3738–3744PubMedCrossRef Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112(24):3738–3744PubMedCrossRef
12.
Zurück zum Zitat Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352(25):2581–2588PubMedCrossRef Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352(25):2581–2588PubMedCrossRef
13.
Zurück zum Zitat Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351(13):1285–1295PubMedCrossRef Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351(13):1285–1295PubMedCrossRef
14.
Zurück zum Zitat European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM), Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG) (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10(10):933–989 European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM), Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG) (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10(10):933–989
15.
Zurück zum Zitat Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958PubMedCrossRef Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958PubMedCrossRef
Metadaten
Titel
A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study
verfasst von
Colin J. Petrie
Adriaan A. Voors
Michele Robertson
Dirk J. van Veldhuisen
Henry J. Dargie
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 1/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0360-x

Weitere Artikel der Ausgabe 1/2012

Clinical Research in Cardiology 1/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.